Cervical cancer screening: epidemiology as the necessary but not sufficient basis of public health practice

Por Schiffman, Mark
Publicado no Prev Med (2017)

Human papillomavirus (HPV) infection and the multi-stage carcinogenesis of cervical cancer

Por Schiffman, Mark, Wentzensen, Nicolas
Publicado em 2013

Methylation testing and self sampling: Filling a gap in cervical cancer screening programs

Por Wentzensen, Nicolas, Schiffman, Mark
Publicado em 2014

Issues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era

Por Schiffman, Mark, Wentzensen, Nicolas
Publicado no Ecancermedicalscience (2015)

A Suggested Approach To Simplify and Improve Cervical Screening in the United States

Por Schiffman, Mark, Wentzensen, Nicolas
Publicado no J Low Genit Tract Dis (2016)

When to test women for human papillomavirus: Cervical screening using HPV testing shows great promise but warrants caution

Por Schiffman, Mark, Castle, Philip E
Publicado em 2006

A novel metric that quantifies risk stratification for evaluating diagnostic tests: The example of evaluating cervical-cancer screening tests across populations

Por Katki, Hormuzd A., Schiffman, Mark
Publicado no Prev Med (2018)

The Use of HPV Seroepidemiology to Inform Vaccine Policy

Por Schiffman, Mark, Safaeian, Mahboobeh, Wentzensen, Nicolas
Publicado no Sex Transm Dis (2009)

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

Por Schiffman, Mark, Clifford, Gary, Buonaguro, Franco M
Publicado em 2009

Triage of HPV positive women in cervical cancer screening

Por Wentzensen, Nicolas, Schiffman, Mark, Palmer, Timothy, Arbyn, Marc
Publicado no J Clin Virol (2015)

Utility of Methylation Markers in Cervical Cancer Early Detection: Appraisal of the State-of-the-Science

Por Wentzensen, Nicolas, Sherman, Mark E., Schiffman, Mark, Wang, Sophia S.
Publicado em 2008

Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106

Por Chen, Zigui, Schiffman, Mark, Herrero, Rolando, Burk, Robert D.
Publicado em 2007

Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?

Por Silkensen, Shannon L., Schiffman, Mark, Sahasrabuddhe, Vikrant, Flanigan, John S.
Publicado no Glob Health Sci Pract (2018)

Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2

Por Castle, Philip E., Schiffman, Mark, Wheeler, Cosette M., Solomon, Diane
Publicado em 2009

The accuracy of colposcopic grading for detection of high grade cervical intraepithelial neoplasia

Por Massad, L. Stewart, Jeronimo, Jose, Katki, Hormuzd A., Schiffman, Mark
Publicado em 2009

Risk assessment to guide the prevention of cervical cancer

Por Castle, Philip E., Sideri, Mario, Jeronimo, Jose, Solomon, Diane, Schiffman, Mark
Publicado em 2007

Risk Estimation for the next generation of cervical cancer prevention programs

Por Katki, Hormuzd A., Wacholder, Sholom, Solomon, Diane, Castle, Philip, Schiffman, Mark
Publicado em 2009

The Clinical Meaning of a Cervical Intraepithelial Neoplasia Grade 1 Biopsy

Por Castle, Philip E., Gage, Julia C., Wheeler, Cosette M., Schiffman, Mark
Publicado em 2011

Evaluation of Any or Type-Specific Persistence of High-Risk Human Papillomavirus for Detecting Cervical Precancer

Por Marks, Morgan A., Castle, Philip E., Schiffman, Mark, Gravitt, Patti E.
Publicado em 2012

POLICY IMPLICATIONS OF ADJUSTING RANDOMIZED TRIAL DATA FOR ECONOMIC EVALUATIONS: A DEMONSTRATION FROM THE ASCUS-LSIL TRIAGE STUDY

Por Campos, Nicole G., Castle, Philip E., Schiffman, Mark, Kim, Jane J.
Publicado em 2011